Showing results (371-380 of 757) with videos related to

Sort By:
Pageof 76
Clinical Chemistry|July 21, 2009
Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cellsSusanne B Schwedler, Thomas Hansen-Hagge, Matthias Reichert, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 15, 2009
[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge]Frank Weidemann, Claudia Sommer, Thomas Duning, et al.
Ultrasound in Medicine & Biology|November 19, 2010
Prominent papillary muscles in Fabry disease: a diagnostic marker?Markus Niemann, Dan Liu, Kai Hu, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2023
Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis CohortJule Pinter, Brendan Smyth, Stefano Stuard, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2024
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trialChristoph Wanner, Masaomi Nangaku, Bettina J Kraus, et al.
Ultrasound in Medicine & Biology|December 27, 2008
Heart valve involvement in Fabry cardiomyopathyFrank Weidemann, Joerg M Strotmann, Markus Niemann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 DiabetesMark E Cooper, Vlado Perkovic, Janet B McGill, et al.
Journal of the American College of Cardiology|May 30, 2015
Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patientsGünther Silbernagel, Günter Fauler, Bernd Genser, et al.
Lancet (London, England)|March 19, 2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional studyMarkus Ketteler, Philipp Bongartz, Ralf Westenfeld, et al.
Cardiovascular Diabetology|November 27, 2020
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Subodh Verma, David Fitchett, et al.
Pageof 76